학술논문

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
Document Type
Article
Source
In: Digestive and Liver Disease. (Digestive and Liver Disease, November 2022, 54(11):1563-1572)
Subject
Language
English
ISSN
18783562
15908658